Littérature scientifique sur le sujet « Cancer »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Cancer ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Cancer"
Basch, Corey H., Charles E. Basch, Grace Clarke Hillyer et Rachel Reeves. « YouTube Videos Related to Skin Cancer : A Missed Opportunity for Cancer Prevention and Control ». JMIR Cancer 1, no 1 (2 mars 2015) : e1. http://dx.doi.org/10.2196/cancer.4204.
Texte intégralJabour, Abdulrahman M., Brian E. Dixon, Josette F. Jones et David A. Haggstrom. « Toward Timely Data for Cancer Research : Assessment and Reengineering of the Cancer Reporting Process ». JMIR Cancer 4, no 1 (1 mars 2018) : e4. http://dx.doi.org/10.2196/cancer.7515.
Texte intégralCorbett, Teresa, Jane C. Walsh, AnnMarie Groarke, Rona Moss-Morris, Eimear Morrissey et Brian E. McGuire. « Cancer-Related Fatigue in Post-Treatment Cancer Survivors : Theory-Based Development of a Web-Based Intervention ». JMIR Cancer 3, no 2 (4 juillet 2017) : e8. http://dx.doi.org/10.2196/cancer.6987.
Texte intégralWilliams, Kate, Abigail Fisher, Rebecca J. Beeken et Jane Wardle. « Availability of Information About Lifestyle for Cancer Survivors in England : A Review of Statutory and Charitable Sector Organizations and Cancer Centers ». JMIR Cancer 1, no 1 (9 mars 2015) : e2. http://dx.doi.org/10.2196/cancer.3521.
Texte intégralBaseman, Janet, Debra Revere et Laura-Mae Baldwin. « A Mobile Breast Cancer Survivorship Care App : Pilot Study ». JMIR Cancer 3, no 2 (26 septembre 2017) : e14. http://dx.doi.org/10.2196/cancer.8192.
Texte intégralvan Eenbergen, Mies C., Lonneke V. van de Poll-Franse, Emiel Krahmer, Suzan Verberne et Floortje Mols. « Analysis of Content Shared in Online Cancer Communities : Systematic Review ». JMIR Cancer 4, no 1 (3 avril 2018) : e6. http://dx.doi.org/10.2196/cancer.7926.
Texte intégralSato, Akira, Eiji Aramaki, Yumiko Shimamoto, Shiro Tanaka et Koji Kawakami. « Blog Posting After Lung Cancer Notification : Content Analysis of Blogs Written by Patients or Their Families ». JMIR Cancer 1, no 1 (18 mai 2015) : e5. http://dx.doi.org/10.2196/cancer.3883.
Texte intégralCarter, Wendy, Karen Fergus, Saunia Ahmad, Deborah McLeod et Joanne Stephen. « Defining the Role of the Online Therapeutic Facilitator : Principles and Guidelines Developed for Couplelinks, an Online Support Program for Couples Affected by Breast Cancer ». JMIR Cancer 1, no 1 (14 avril 2015) : e4. http://dx.doi.org/10.2196/cancer.3887.
Texte intégralKilsdonk, Ellen, Eline van Dulmen-den Broeder, Helena J. van der Pal, Nynke Hollema, Leontien C. Kremer, Marry M. van den Heuvel-Eibrink, Flora E. van Leeuwen, Monique W. Jaspers et Marleen H. van den Berg. « Effect of Web-Based Versus Paper-Based Questionnaires and Follow-Up Strategies on Participation Rates of Dutch Childhood Cancer Survivors : A Randomized Controlled Trial ». JMIR Cancer 1, no 2 (24 novembre 2015) : e11. http://dx.doi.org/10.2196/cancer.3905.
Texte intégralKim, Matthew. « Evaluation of a Web-Based App Demonstrating an Exclusionary Algorithmic Approach to TNM Cancer Staging ». JMIR Cancer 1, no 1 (2 avril 2015) : e3. http://dx.doi.org/10.2196/cancer.4019.
Texte intégralThèses sur le sujet "Cancer"
CATTIER, JEAN-MICHEL. « Contribution a l'etude de l'anurie dans les cancers pelviens : cancer de prostate, cancer colo-rectal, cancer du col de l'uterus ». Limoges, 1988. http://www.theses.fr/1988LIMO0208.
Texte intégralFruka, Tayra. « An evaluation of cancer biomarkers in normal ovarian epithelial cells and ovarian cancer cell lines ». University of the Western Cape, 2019. http://hdl.handle.net/11394/6920.
Texte intégralIntroduction: Globally, there are over 190,000 new reported cases of ovarian cancers per annum. This comprises 3% to 4% of all cancers in women. Ovarian cancer is one of the leading causes of deaths in women. Ovarian cancer is the second most diagnosed gynaecological malignancy and over all the fifth cause leading to death among all types of cancer in the UK in 2004. More than 70% of epithelial ovarian cancers are diagnosed at an advanced stage. Consequently, the prognosis is poor and the mortality rate high. Thus, the survival rate is affected by how far the disease has progressed or spread. A dire need exists to identify ovarian cancer biomarkers, which could be used as good indicators of expression in ovarian cancer cells in vitro Aim: The aim of this study was to analyse selected cancer biomarkers, which are currently under intense investigation for their suitability to diagnose epithelial ovarian cancer at an early stage. These biomarkers were analysed in terms of their in vitro expression in normal epithelial cells and ovarian cancer cell lines, which allows for their genomic and proteomic classification. The expression analysis of each biomarker is related to the malignancy of a tumour and, therefore, advocates its use for potential future improvement of sensitive tumour markers. Methods: The primary human ovarian surface epithelial cell line (HOSEpiC), SKOV-3 cells and the OAW42 human epithelial ovarian tumour cell lines were used to evaluate the selected cancer biomarkers. Cells were cultured using appropriate media and supplements, and real-time quantitative polymerase chain reaction (RT-PCR) utilized to validate expression levels of the following genes: HDAC1, HDAC2, HDCA3, HDAC5, HDAC6, HDAC7, HDAC8, LPAR1, LPAR2, MUC16 and FOSL1, against normal housekeeping genes GAPDH and HPRT. In addition, immunocytochemistry was also used in the validation process of the aforementioned genes. Significance: ovarian cancer cells express gene signatures, which pose significant challenges for cancer drug development, therapeutics, prevention and management. The present study is an effort to explore ovarian cancer biomarkers to provide a better diagnostic method that may offer translational therapeutic possibilities to increase five- year survival rate. Results: HDAC5, HDAC6, LPAR1, LPAR2 and MUC16 expressed distinctively in ovarian cancers matched to other tissues or cancer types have already been identified by RT-QPCR and confirmed by immunocytochemistry and efforts to generate monoclonal antibodies to the other six genes (HDAC1, HDAC2, HDAC3, HDAC7, HDAC8 and FOSL1) encoded proteins are underway. Conclusions: here we provide strong evidence suggesting that HDAC5, HDAC6, LPAR1, LPAR2, except MUC16 are up regulated in ovarian cancer. These data were confirmed by examining Human Protein Atlas (HPA) databases, in addition to protein expression of HDAC5, HDAC6, LPAR1, LPAR2 and MUC16 in cells cytoplasm. For future prospective, using other techniques that assess the variant expression that could explain the release of these gene candidates into the circulation with serum tumour markers, and protein expression will be strengthened.
Engler, Jennifer [Verfasser]. « Cancer Care and Cancer Patients’ Experiences with Cancer / Jennifer Engler ». Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2019. http://d-nb.info/1180994191/34.
Texte intégralStocks, Tanja. « Metabolic factors and cancer risk : prospective studies on prostate cancer, colorectal cancer, and cancer overall ». Doctoral thesis, Umeå universitet, Urologi och andrologi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-22567.
Texte intégralEberst, Guillaume Nicolas. « Seconds cancers après traitement curatif d'un cancer broncho-pulmonaire ». Electronic Thesis or Diss., Bourgogne Franche-Comté, 2023. http://www.theses.fr/2023UBFCE029.
Texte intégralThe first objective of the 2014-2019 cancer plan was to cure more patients by promoting earlier diagnosis. This objective gives hope for more diagnosis at early stages accessible to surgical resection. Currently, excisional surgery for non-small cell bronchopulmonary cancer (NSCLC) is the treatment offering the most hope for a cure. This thesis work is particularly interested in the future of operated patients.Despite a curative intention, patients operated on for NSCLC are at risk of recurrence of the operated cancer but also have a higher risk of second cancer, and in particular second primary lung cancer (SPLC), higher than that of the general population. , of the order of 20% cumulative incidence at 10 years.When a lung lesion with the same histological diagnosis as the operated cancer occurs, the differential diagnosis between recurrence of the operated cancer or SPLC is difficult. Several definitions exist. Based on the hypothesis that recurrences indicate an aggressiveness of the cancerous disease, and therefore most often have a worse prognosis than second cancers, we first conducted a Cochrane systematic review of the set of definitions used in the literature in order to identify the one which offers the best prognostic distinction, on which to base the differential diagnosis between recurrence of operated cancer and SCBP.A few years ago, immunotherapy established itself in the therapeutic arsenal for bronchopulmonary cancer. First used in the metastatic situation, immunotherapy is now tested in the perioperative situation in numerous trials. However, due to the diversity of combinations and therapeutic strategies, not all of which have been compared with each other, uncertainty remains regarding the best perioperative therapy for patients undergoing surgery for early-stage NSCLC. We initiated a systematic review of interventional trials with network meta-analysis according to the Cochrane method on the effectiveness of these perioperative treatments in patients with non-small cell lung cancer.The IFCT-0302 study is the only large randomized surveillance study of NSCLC patients. It included 1775 patients. Its objective was to compare the overall survival of two monitoring strategies: by clinic and chest x-rays in the control group, and by clinic, chest x-rays and thoraco-abdominal scans in the experimental group. Patient-described quality of life (HRQoL) is a measure of three domains of perceived health: physical, social, and emotional. QoL is impacted by a medical condition or its treatment. Evidence suggests that lung cancer surgery has a significant impact on QoL. The objective of our work was to evaluate the influence of the type of surveillance on HRQoL in the population of the IFCT-0302 study.When an abnormal lung image is detected, its histological diagnosis is frequently obtained by transthoracic puncture guided by the scanner. The main complication of the procedure is pneumothorax. Hospital constraints do not allow all patients to be hospitalized after a transthoracic puncture. In this third axis, we worked on the validation of a predictive score for the occurrence of delayed pneumothorax after a CT-guided transparietal lung biopsy, in order to select patients who must be monitored in conventional hospitalization. This work was carried out on a cohort of patients from Besançon University Hospital, one part of the cohort having made it possible to develop the score, the other to validate it. Finally, external validation work on a cohort of patients from the Bichat – Claude Bernard Hospital was carried out
Pieters, Huibrie. « From 'Cancer Patient' to 'Cancer Survivor' oldest breast cancer survivors in transition / ». Diss., Restricted to subscribing institutions, 2009. http://proquest.umi.com/pqdweb?did=2023818721&sid=1&Fmt=2&clientId=1564&RQT=309&VName=PQD.
Texte intégralJégu, Jérémie. « Cancer ultérieur chez les survivants d'un premier cancer : incidence et impact sur la survie ». Thesis, Strasbourg, 2014. http://www.theses.fr/2014STRAJ006/document.
Texte intégralThe objectives of this PhD thesis were: to study the trends of the risk of second primary cancer (SPC) among patients with a head and neck (HNSCC) cancer in Bas-Rhin, to provide first nationwide estimates of the risk of SPC in France and to assess the survival of patients with a HNSCC depending on their history of cancer. This work showed that : 1) The excess risk of SPC of head and neck and esophagus sites decreased by 53% over three decades among patients with a HNSCC, and that the excess risk of SPC of the lung did not change significantly. 2) The risk of SPC among cancer survivors in France was increased by 36% compared to the general population. 3) History of cancer was strongly associated with survival among HNSCC patients. Several epidemiological and clinical research perspectives can be established based on this work. These results also present an interest in a public health perspective in the framework of the third cancer plan
陳潔盈 et Kit-ying Loucia Chan. « Expression analysis of Candidate cancer genes in non-small cell lung cancer ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B45011163.
Texte intégralSoerjomataram, Isabelle. « Multiple primary cancers in patients with breast ans skin cancer ». [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10779.
Texte intégralAlmutairi, Mikhlid Hammad. « Identification of novel human cancer-testis-antigen genes in cancers ». Thesis, Bangor University, 2014. https://research.bangor.ac.uk/portal/en/theses/identification-of-novel-human-cancertestisantigen-genes-in-cancers(015fda5b-5bd3-42c1-a610-811f0acde19a).html.
Texte intégralLivres sur le sujet "Cancer"
Otto, Florian, et Manfred P. Lutz, dir. Early Gastrointestinal Cancers II : Rectal Cancer. Cham : Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-08060-4.
Texte intégralTimmermann, Carsten, et Elizabeth Toon, dir. Cancer Patients, Cancer Pathways. London : Palgrave Macmillan UK, 2012. http://dx.doi.org/10.1057/9781137272089.
Texte intégralWyatt, Debbie, et Nicholas Hulbert-Williams. Cancer and Cancer Care. 1 Oliver’s Yard, 55 City Road London EC1Y 1SP : SAGE Publications Ltd, 2015. http://dx.doi.org/10.4135/9781473920620.
Texte intégralNational Cancer Institute (U.S.), dir. President's Cancer Panel, National Cancer Program : Cancer and poverty. Silver Spring, Md : Eberlin Reporting Center, 1991.
Trouver le texte intégralBozzone, Donna M. Biology of cancer : Cancer genetics. New York NY : Chelsea House, 2007.
Trouver le texte intégralWhitehouse, J. M. A. Cancer. 2e éd. Oxford : Oxford University Press, 1996.
Trouver le texte intégralBose, S. M. Cancer. New Delhi : National Book Trust, India, 2002.
Trouver le texte intégralRodgers, Joann Ellison. Cancer. New York : Chelsea House, 1990.
Trouver le texte intégralHerda, D. J. Cancer. New York : F. Watts, 1989.
Trouver le texte intégralBradbury, Robert H., dir. Cancer. Berlin, Heidelberg : Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-33120-9.
Texte intégralChapitres de livres sur le sujet "Cancer"
Zarisfi, Mohammadreza, Tu Nguyen, Jessie R. Nedrow et Anne Le. « The Heterogeneity Metabolism of Renal Cell Carcinomas ». Dans The Heterogeneity of Cancer Metabolism, 117–26. Cham : Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_8.
Texte intégralMorris, Katrina Marie, et Katherine Belov. « Cancer Immunology of Transmissible Cancers ». Dans Cancer Immunology, 419–28. Berlin, Heidelberg : Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-44006-3_22.
Texte intégral« Colorectal Cancer : An Overview ». Dans Gastrointestinal Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-gastrointestinal-cancers-colorectal-cancer.
Texte intégral« Organ Sparing Surgery in Testicular Cancer ». Dans Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-testicular-cancer.
Texte intégral« Prostate Cancer Diagnosis : Biopsy Approaches ». Dans Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-prostate-cancer-biopsy.
Texte intégral« The Etiology of Bladder Cancer ». Dans Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-etiology-bladder-cancer.
Texte intégral« The Epidemiology of Testicular Cancer ». Dans Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-epidemiology-testicular-cancer.
Texte intégral« The Epidemiology of Penile Cancer ». Dans Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-epidemiology-penile-cancer.
Texte intégral« The Epidemiology of Stomach Cancer ». Dans Gastrointestinal Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-gastrointestinal-cancers-stomach-cancer-epidemiology.
Texte intégral« Improving Prostate Cancer Care through Quality Assurance Programs ». Dans Urologic Cancers. Exon Publications, 2022. http://dx.doi.org/10.36255/exon-publications-urologic-cancers-prostate-cancer-care.
Texte intégralActes de conférences sur le sujet "Cancer"
Rodrigues, Milena de Freitas, Ariane Silva da Rocha, David Siqueira Gonçalves, Maria Paula Curado et Maria Nirvana da Cruz Formiga. « Hereditary cancer syndromes in patients with second primary breast cancer ». Dans Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1067.
Texte intégralLacerda, Elisângela de Paula Silveira, Rebeca Mota Goveia, Paula Francinete Faustino Silva, Thais Bonfim Teixeira et Ruffo de Freitas-Junior. « HEREDITARY BREAST AND OVARIAN CANCER PATIENTS HAVE A FAMILY HISTORY OF CANCER OUTSIDE THE SPECTRUM OF THE SYNDROME, MIMICKING LYNCH AND LI–FRAUMENI SYNDROMES ». Dans Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2030.
Texte intégralHider, Nabilah Hanani, Anis Salwa Binti Mohd Khairuddin et Effariza Binti Hanafi. « VGG Classification Model for Lung Cancer Diagnosis ». Dans International Technical Postgraduate Conference 2022. AIJR Publisher, 2022. http://dx.doi.org/10.21467/proceedings.141.9.
Texte intégralMelo, Maria Eduarda Bernardino Martins, Gabriela Prado Lopes, Darley Lima Ferreira Filho, Irnanda Layanna Gomes Oliveira et Maria Eduarda Vasconcelos Florêncio Cavalcanti. « MALE BILATERAL BREAST CANCER : CASE REPORT ». Dans Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1077.
Texte intégralMoreno, Andre, Kimberly Masiero Cola, Larissa Heberle et Marcelo Moreno. « RELATIONSHIP BETWEEN IMMUNOHISTOCHEMICAL CHARACTERIZATION AND FORM OF DIAGNOSIS OF BREAST CANCER ». Dans Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1008.
Texte intégralEl-Helou, Etienne, Catalin-Florin Pop, Ammar Shall, Manar Zaiter, Jessica Naccour, Huu Hoang, Thi Hoa Nguyen et Xuan Dung Ho. « PRIMARY INVASIVE DUCTAL CARCINOMA OF AXILLARY ACCESSORY BREAST ». Dans Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2094.
Texte intégralLiu, Ziyu, Wei Shao, Jie Zhang, Min Zhang et Kun Huang. « Transfer Learning via Optimal Transportation for Integrative Cancer Patient Stratification ». Dans Thirtieth International Joint Conference on Artificial Intelligence {IJCAI-21}. California : International Joint Conferences on Artificial Intelligence Organization, 2021. http://dx.doi.org/10.24963/ijcai.2021/380.
Texte intégral« Case series : Breast and ovarian cancer syndrome ». Dans 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685364.
Texte intégral« Case series : Breast and ovarian cancer syndrome ». Dans 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685348.
Texte intégralFerreira, Guilherme Ribeiro, Bianca Dias Socci, Héctor Hugo Queiroz Francto, Yasmin Arroyo de Moraes et João Lucas de Moraes. « Breast cancer mortality in Brazil between the years 2000 and 2020 : ecological study ». Dans II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-026.
Texte intégralRapports d'organisations sur le sujet "Cancer"
Ramsey, Imogen, Kate Kennedy, Deborah Forsythe, Micah Peters, Greg Sharplin, Nadia Corsini et Marion Eckert. Cancer control plans. The Sax Institute, juin 2020. http://dx.doi.org/10.57022/jkea9139.
Texte intégralAziz, Md Abdul, Tahmina Akter et Mohammad Safiqul Islam. Effect of miR-196a2 rs11614913 polymorphism on cancer susceptibility : evidence from an updated meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, mai 2022. http://dx.doi.org/10.37766/inplasy2022.5.0027.
Texte intégralFreire, Mariana, Diana Martins, Maria Filomena Botelho et Fernando Mendes. Biomarkers of resistance mechanisms in innovative lung cancer treatments - A systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, septembre 2022. http://dx.doi.org/10.37766/inplasy2022.9.0011.
Texte intégralParsons, Helen M. Nutrition as Prevention for Improved Cancer Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), mai 2023. http://dx.doi.org/10.23970/ahrqepccer260.
Texte intégralStanton, Elliot, et Natasha Mutebi. Food, diet, nutrition and cancer. Parliamentary Office of Science and Technology, UK Parliament, avril 2024. http://dx.doi.org/10.58248/pn718.
Texte intégralMoxham-Hall, Vivienne, Anton du Toit, Sallie Newell, Stuart Brentnall, Deshanie Rawlings et Eileen Goldberg. Proton beam therapy : A rapid review of the evidence since 2020. The Sax Institute, avril 2023. http://dx.doi.org/10.57022/tjvf1783.
Texte intégralSquiers, Linda, Mariam Siddiqui, Ishu Kataria, Preet K. Dhillon, Aastha Aggarwal, Carla Bann, Molly Lynch et Laura Nyblade. Perceived, Experienced, and Internalized Cancer Stigma : Perspectives of Cancer Patients and Caregivers in India. RTI Press, avril 2021. http://dx.doi.org/10.3768/rtipress.2021.rr.0044.2104.
Texte intégralWang, Ying yuan, Zechang Chen, Luxin Zhang, Shuangyi Chen, Zhuomiao Ye, Tingting Xu et Yingying Zhang c. A systematic review and network meta-analysis : Role of SNPs in predicting breast carcinoma risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, février 2022. http://dx.doi.org/10.37766/inplasy2022.2.0092.
Texte intégralKang, Jing, Jun Zhang, Zongsheng Tian, Ye Xu, Jiangbi Li et Mingxina Li. The efficacy and safety of immune-checkpoint inhibitor plus chemotherapy versus chemotherapy for non-small cell lung cancer : an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, mai 2022. http://dx.doi.org/10.37766/inplasy2022.5.0156.
Texte intégralWang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang et al. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients : a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, juillet 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.
Texte intégral